Article
Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.
Antimicrobial agents and chemotherapy - 1 Apr 2013
Reeves Analise Z, Campbell Patricia J, Sultana Razvan, Malik Seidu, Murray Megan, Plikaytis Bonnie B, Shinnick Thomas M, Posey James E
Abstract excerpt
Since the discovery of streptomycin's bactericidal activity against Mycobacterium tuberculosis, aminoglycosides have been utilized to treat tuberculosis (TB). Today, the aminoglycosides kanamycin and amikacin are used to treat multidrug-resistant (MDR) TB, and resistance to any of the second-line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
